The HCPLive Rheumatology condition center page is a comprehensive resource for clinical news and insights on rheumatologic disease. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for arthritis, gout, nr-AxSpA, and more.
October 8th 2024
An interim analysis of the PRO-SPIRIT study compared outcomes at 3 months after starting new treatments for psoriatic arthritis.
Collaborating Across the Continuum™: The Role of Multidisciplinary Care in the Management of Patients with Exocrine Pancreatic Insufficiency
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
October 16, 2024
Register Now!
Tackling Inequities in IBD: Inclusive Solutions for Elevated Patient Care
October 26, 2024
Register Now!
6th Annual Advanced Practice Collaborative
View More
SimulatED™: Personalizing Treatment Choices to Achieve Glycemic and Weight Management Goals
View More
Cases and Conversations™: Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis
November 18, 2024
Register Now!
Shaping the Management of COPD with Biologic Therapy
View More
Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes
View More
Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II
View More
Expert Illustrations & Commentaries™: Exploring the Role of Novel Agents for the Management of IgA Nephropathy
View More
Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies
View More
'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care
View More
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
Clinical ShowCase™: Finding the Best Path Forward for Patients with COPD
View More
A Tethered Approach to Type 2 Diabetes Care – Connecting Insulin Regimens with Digital Technology
View More
Surv.AI Says™: What Clinicians and Patients Are Saying About Glucose Management in the Technology Age
View More
Clinical ShowCase™: Forming a Personalized Treatment Plan for a Patient With ANCA-Associated Vasculitis
View More
Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care
View More
SimulatED™: Diagnosing and Treating Alzheimer’s Disease in the Modern Era
View More
Patient, Provider & Caregiver Connection™: Implementing an Effective Management Plan to Improve Outcomes in IgA Nephropathy
View More
Evaluating a Young Patient with Joint Pain and Stiffness Part 2
You see a 29-year-old female insurance saleswoman with a 6-week history of joint pains and swelling affecting both hands and wrists, both feet and her left knee. Her symptoms are worse when she first gets up in the morning and it takes a few hours before her joints seem to loosen up.
Rheumatology and Rashes: Insights from the AAD Annual Meeting
April 9th 2015Lupus is the condition that most frequently requires attention to skin problems, but it's far from the only reason for a rheumatologist's patient to see a dermatologist. In the case of lupus, however, the lesion may be a clue to prognosis.
Insulin Resistance Higher in Rheumatoid Arthritis Patients
The increased insulin resistance seen in rheumatoid arthritis (RA) patients compared to non-RA controls did not contribute to additional atherosclerosis risk, according to research published in Arthritis & Rheumatology.
Joint Health Supplements Seek Second Look
With a mix of elderly and active people filling out the population joint health can be an important part of everyday life. Recent studies have shown that certain supplements can help keep joints healthy for these people and beyond.
Rheumatologist Advocacy Wins Reprieve on Viscosupplementation "Ban"
April 1st 2015Prompt action by Alabama rheumatologists has caused Blue Cross Blue Shield to rethink a policy denying all claims for injections into knees with osteoarthritis. But a similar "ban" on hyaluronic acid in neighboring Florida takes effect today.
Patients Describe a Different PsA. New Assessment Tools Needed?
April 1st 2015A major disconnect in psoriatic arthritis treatment: Assessment tools and guidelines largely ignore flares. But over half of patients in two new surveys report severe flares or completely unremitting disease. Both are linked to poor outcomes.
Future Blood Test for Osteoarthritis Uses Current Assays
April 1st 2015A second biomarker panel shows promise in distinguishing osteoarthritis from rheumatoid arthritis early enough to prevent joint damage. This one relies partly on lack of antibody response to citrullinated proteins in early osteoarthritis.